H.R.64 - Patients First Act of 2019116th Congress (2019-2020)
|Sponsor:||Rep. Banks, Jim [R-IN-3] (Introduced 01/03/2019)|
|Committees:||House - Energy and Commerce|
|Latest Action:||House - 01/25/2019 Referred to the Subcommittee on Health. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.64 — 116th Congress (2019-2020)All Information (Except Text)
Introduced in House (01/03/2019)
Patients First Act of 2019
This bill requires the National Institutes of Health (NIH) to support stem cell research. Specifically, the NIH must conduct and support basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of, or treatments for, diseases and other adverse health conditions. However, such techniques must not involve (1) the creation of a human embryo for research purposes; (2) the destruction or discarding of, or risk of injury to, a human embryo; or (3) the use of any stem cell the derivation or provision of which would be inconsistent with this bill.
The NIH must also report on peer-reviewed stem cell research proposals that were not funded.